Senior Principal Scientist
Novartis, Zurich, Switzerland
Christoph Dumelin, PhD, is a group leader at the Novartis Institutes of Biomedical Research in Basel, Switzerland. Christoph leads a team which applies encoded library technologies for the identification of low molecular weight and peptide ligands to targets across multiple disease areas. A particular focus of his work is the exploration of novel therapeutics modalities such as radioligand therapeutics. Before joining Novartis, he worked on DNA-encoded libraries at X-Chem Pharmaceuticals, Waltham, Massachusetts, USA, and on whole-blood pool contrast agents at Philochem, Zurich, Switzerland. He obtained his M.Sc. in biochemistry from the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland, and his Ph.D. in pharmaceutical sciences at the ETH Zurich with Dario Neri. He completed his postdoctoral training in chemical biology with David Liu at Harvard University, Cambridge, USA.
Disclosure information not submitted.
Tuesday, February 8, 2022
10:00 AM – 11:30 AM